Form D · Other Technology
Fatigue Science Technologies International Ltd.
Vancouvler, A1 · CIK 0001853679
Offering snapshot reported Sep 18, 2026 · SEC filing
- Reported sold
- $75K Offering amount: $75K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2026 | Initial | $75,000 | No comparison | 1 | SEC filing |
| Sep 18, 2026 | Initial | $0 | No comparison | 1 | SEC filing |
| Mar 29, 2021 | Amendment | $136,814 | $0vs Mar 26, 2021 | 3 | SEC filing |
| Mar 26, 2021 | Initial | $10 | No comparison | 7 | SEC filing |
| Mar 26, 2021 | Initial | $136,814 | No comparison | 3 | SEC filing |
| Mar 26, 2021 | Initial | $9,997 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598158
Source: Form D, filed Sep 18, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Bryne | Director |
| Dan Eisenhardt | Director |
| Ryan Marcinew | Executive |
| Andrew Morden | Director, Executive |
| Laurie Wallace | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
200 110 W Hastings Street
Vancouvler, A1, V6B 1G8
Vancouvler, A1, V6B 1G8